Literature DB >> 10395081

Reversible phosphorylation control of skeletal muscle pyruvate kinase and phosphofructokinase during estivation in the spadefoot toad, Scaphiopus couchii.

K J Cowan1, K B Storey.   

Abstract

Both pyruvate kinase (PK) and phosphofructokinase (PFK) occur in two different forms, separable by isoelectric focusing (IEF), in skeletal muscle of the spadefoot toad Scaphiopus couchii. During estivation (aerobic dormancy) the proportions of the two forms changed compared with controls; in both cases the amount of enzyme in Peak I (pI = 5.3-5.4) decreased whereas activity in Peak II (isoelectric point = 6.2-6.4) increased. In vitro incubation of crude muscle extracts with 32P-ATP under conditions that promoted the activity of cAMP-dependent protein kinase led to strong radiolabeling associated with Peak I, but not Peak II, and reverse phase HPLC confirmed that 32P was associated with the subunits of both PK and PFK found in Peak I. Specific radiolabeling of Peak I PK and PFK by protein kinase A was further confirmed using immunoprecipitation. In total, this information allowed identification of the Peaks I and II enzymes as the phosphorylated and dephosphorylated forms, respectively, and the effect of estivation was to increase the proportion of dephosphorylated PK and PFK in muscle. Analysis of the kinetic properties of partially purified PK and PFK revealed significant kinetic differences between the two forms of each enzyme. For PK, the Peak II (low phosphate) enzyme showed a 1.6-fold higher Km for phosphoenolpyruvate and a 2.4-fold higher Ka for fructose-1,6-bisphosphate than did the Peak I (high phosphate) form. These kinetic properties suggest that Peak II PK is the less active form, and coupled with the shift to predominantly the Peak II form during estivation (87% Peak II vs. 13% Peak I), are consistent with a suppression of PK activity in estivating muscle, as part of the overall metabolic rate depression of the estivating state. A similar shift to predominantly the Peak II, low phosphate, form of PFK (75% Peak II, 25% Peak I) in muscle of estivating animals is also consistent with metabolic suppression since phosphorylation of vertebrate skeletal muscle PFK is typically stimulated during exercise to enhance enzyme binding to myofibrils in active muscle. Peak II PFK also showed reduced sensitivity to inhibition by Mg:ATP (I50 50% higher) compared with the Peak I form suggesting that the enzyme in estivating muscle is less tightly regulated by cellular adenylate status than in awake toads. The data indicate that reversible phosphorylation control over the activity states of enzymes of intermediary metabolism is an important mechanism for regulating transitions between dormant and active states in estivating species.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10395081     DOI: 10.1023/a:1006932221288

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  14 in total

1.  A simple computer program with statistical tests for the analysis of enzyme kinetics.

Authors:  S P Brooks
Journal:  Biotechniques       Date:  1992-12       Impact factor: 1.993

2.  Phosphofructokinase from a vertebrate facultative anaerobe: effects of temperature and anoxia on the kinetic parameters of the purified enzyme from turtle white muscle.

Authors:  S P Brooks; K B Storey
Journal:  Biochim Biophys Acta       Date:  1990-02-09

3.  The role of phosphorylation in the interaction of rabbit muscle phosphofructokinase with F-actin.

Authors:  M A Luther; J C Lee
Journal:  J Biol Chem       Date:  1986-02-05       Impact factor: 5.157

4.  Regulation of phosphofructokinase from muscle and liver of rainbow trout by protein phosphorylation.

Authors:  J Y Su; K B Storey
Journal:  Biochem Mol Biol Int       Date:  1994-08

5.  A program for analyzing enzyme rate data obtained from a microplate reader.

Authors:  S P Brooks
Journal:  Biotechniques       Date:  1994-12       Impact factor: 1.993

6.  Properties of phospho and dephospho forms of muscle phosphofructokinase.

Authors:  L G Foe; R G Kemp
Journal:  J Biol Chem       Date:  1982-06-10       Impact factor: 5.157

7.  Microcentrifuge desalting: a rapid, quantitative method for desalting small amounts of protein.

Authors:  E Helmerhorst; G B Stokes
Journal:  Anal Biochem       Date:  1980-05-01       Impact factor: 3.365

8.  Antioxidant defenses and lipid peroxidation damage in estivating toads, Scaphiopus couchii.

Authors:  J E Grundy; K B Storey
Journal:  J Comp Physiol B       Date:  1998-03       Impact factor: 2.200

Review 9.  Metabolic regulation in mammalian hibernation: enzyme and protein adaptations.

Authors:  K B Storey
Journal:  Comp Biochem Physiol A Physiol       Date:  1997-12

10.  Protein-induced inactivation and phosphorylation of rabbit muscle phosphofructokinase.

Authors:  Z Z Zhao; D A Malencik; S R Anderson
Journal:  Biochemistry       Date:  1991-02-26       Impact factor: 3.162

View more
  4 in total

1.  Purification and characterization of skeletal muscle pyruvate kinase from the hibernating ground squirrel, Urocitellus richardsonii: potential regulation by posttranslational modification during torpor.

Authors:  Ryan A V Bell; Kenneth B Storey
Journal:  Mol Cell Biochem       Date:  2017-09-16       Impact factor: 3.396

2.  Purification and Regulation of Pyruvate Kinase from the Foot Muscle of the Anoxia and Freeze Tolerant Marine Snail, Littorina littorea.

Authors:  Michael B Smolinski; Anchal Varma; Stuart R Green; Kenneth B Storey
Journal:  Protein J       Date:  2020-10-23       Impact factor: 2.371

3.  Inhibition of expression of the circadian clock gene Period causes metabolic abnormalities including repression of glycometabolism in Bombyx mori cells.

Authors:  Hui Tao; Xue Li; Jian-Feng Qiu; Wen-Zhao Cui; Yang-Hu Sima; Shi-Qing Xu
Journal:  Sci Rep       Date:  2017-04-10       Impact factor: 4.379

Review 4.  Traditional and Medical Applications of Fasting.

Authors:  Francesco Visioli; Carla Mucignat-Caretta; Francesca Anile; Stefan-Alexandru Panaite
Journal:  Nutrients       Date:  2022-01-19       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.